Published in BMC Cancer on October 25, 2012
Trial of Tomotherapy in Breast Cancer (TomoBreast) | NCT00459628
Feasibility Study of Accelerated Preoperative Radiotherapy for Early Breast Cancer | NCT02858934
Breast Cancer Survivorship & Work-Related Cognitive Limitation (BCSurvivorship) | NCT02303145
Clinical and technological transition in breast cancer. Rep Pract Oncol Radiother (2013) 0.93
Does abortion reduce self-esteem and life satisfaction? Qual Life Res (2014) 0.79
Breast conserving treatment for breast cancer: dosimetric comparison of sequential versus simultaneous integrated photon boost. Biomed Res Int (2014) 0.77
The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up. Ann Surg Oncol (2015) 0.77
Hypofractionated whole breast radiotherapy: current perspectives. Breast Cancer (Dove Med Press) (2015) 0.77
Image-guided radiotherapy for cardiac sparing in patients with left-sided breast cancer. Front Oncol (2014) 0.76
Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial. Onco Targets Ther (2017) 0.75
A preliminary study of manipulation under anaesthesia for secondary frozen shoulder following breast cancer treatment. Ann R Coll Surg Engl (2014) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol (2006) 20.28
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys (1995) 15.12
Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med (1999) 6.83
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (2008) 6.50
Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med (2010) 4.63
Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst (2002) 4.33
Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol (2006) 4.25
Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst (2004) 4.24
Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med (1999) 4.04
The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol (1996) 3.68
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol (2008) 3.31
Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. J Natl Cancer Inst (2006) 3.11
Radiation therapy for early-stage breast cancer after breast-conserving surgery. N Engl J Med (2009) 2.89
Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol (2010) 2.57
Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum (1997) 2.42
Innovations in image-guided radiotherapy. Nat Rev Cancer (2007) 1.98
LENT SOMA tables. Radiother Oncol (1995) 1.65
Health-related quality of life measured by the EORTC QLQ-C30--reference values from a large sample of Swedish population. Acta Oncol (2000) 1.62
Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol (1990) 1.51
Post mastectomy adjuvant radiotherapy in breast cancer: a comparision of three hypofractionated protocols. J Pak Med Assoc (2009) 1.48
Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer (2010) 1.47
A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. Health Technol Assess (2007) 1.34
Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol (2002) 1.34
Health-related quality of life and cancer clinical trials. Ther Adv Med Oncol (2011) 1.30
Interpreting the meaningfulness of changes in health-related quality of life scores: lessons from studies in adults. Int J Cancer Suppl (1999) 1.29
Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother Oncol (2000) 1.26
ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast. Int J Radiat Oncol Biol Phys (2009) 1.20
The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group. Cancer (2000) 1.14
Fatigue in patients with adjuvant radiation therapy for breast cancer: long-term follow-up. J Cancer Res Clin Oncol (2004) 1.12
DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy. Strahlenther Onkol (2007) 1.05
First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). Radiother Oncol (2011) 1.03
Perceived symptoms and quality of life in women with breast cancer receiving radiation therapy. Eur J Oncol Nurs (2000) 1.02
Quality of life of women treated with radiotherapy for breast cancer. Support Care Cancer (2007) 1.01
Absence of adverse early quality of life outcomes of radiation therapy in breast conservation therapy for early breast cancer. Australas Radiol (2005) 0.94
Radiotherapy for breast cancer. J Natl Cancer Inst (2005) 0.92
Hypofractionation versus conventional fractionation radiotherapy after conservative treatment of breast cancer: early skin reactions and cosmetic results. J Egypt Natl Canc Inst (2004) 0.91
Concerns, affect, and cognitive disruption following completion of radiation treatment for localized breast or prostate cancer. Oncol Nurs Forum (1996) 0.84
The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients. Int J Radiat Oncol Biol Phys (1990) 0.82
Women with breast cancer: their quality of life following a course of radiation therapy. J Adv Nurs (1994) 0.80
Historical and methodological perspectives on cancer outcomes research. Oncology (Williston Park) (1995) 0.78
Hypofractionated radiation therapy in breast cancer: a revolutionary breakthrough or a long way to go? J Clin Oncol (2007) 0.76
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet (2002) 10.17
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. Lancet Oncol (2010) 4.61
Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer. Eur J Nucl Med Mol Imaging (2012) 2.23
Innovations in image-guided radiotherapy. Nat Rev Cancer (2007) 1.98
Definition of gross tumor volume in lung cancer: inter-observer variability. Radiother Oncol (2002) 1.52
The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol (2004) 1.51
Ratios of involved nodes in early breast cancer. Breast Cancer Res (2004) 1.50
Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol (2006) 1.49
Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer (2007) 1.48
Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers. Int J Radiat Oncol Biol Phys (2008) 1.41
A (short) history of image-guided radiotherapy. Radiother Oncol (2008) 1.40
Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial. Int J Radiat Oncol Biol Phys (2010) 1.39
Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol (2002) 1.37
Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations. Surg Neurol (2009) 1.35
The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network. Radiat Oncol (2007) 1.24
Geometric accuracy of a novel gimbals based radiation therapy tumor tracking system. Radiother Oncol (2011) 1.24
Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer (2004) 1.23
Dosimetric assessment of static and helical TomoTherapy in the clinical implementation of breast cancer treatments. Radiother Oncol (2009) 1.18
Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity. Radiother Oncol (2006) 1.16
Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma. Cancer Treat Rev (2008) 1.14
Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies. Eur J Cancer (2012) 1.13
Preoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowel. Int J Radiat Oncol Biol Phys (2009) 1.12
A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients. Radiat Oncol (2013) 1.08
Risk of second breast cancer according to estrogen receptor status and family history. Breast Cancer Res Treat (2010) 1.07
Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer. Int J Oncol (2003) 1.07
Clinical evaluation of a robotic 6-degree of freedom treatment couch for frameless radiosurgery. Int J Radiat Oncol Biol Phys (2011) 1.07
Intraspinal epidermoid cyst successfully treated with radiotherapy: case report. Neurosurgery (2003) 1.04
The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer (2008) 1.04
Six dimensional analysis with daily stereoscopic x-ray imaging of intrafraction patient motion in head and neck treatments using five points fixation masks. Med Phys (2006) 1.02
Modeling the effect of tumor size in early breast cancer. Ann Surg (2005) 1.01
Setup accuracy of the Novalis ExacTrac 6DOF system for frameless radiosurgery. Int J Radiat Oncol Biol Phys (2011) 1.01
Lung cancer mortality risk among breast cancer patients treated with anti-estrogens. Cancer (2011) 1.00
Quality assurance of a system for improved target localization and patient set-up that combines real-time infrared tracking and stereoscopic X-ray imaging. Radiother Oncol (2003) 0.99
Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial. Radiat Oncol (2012) 0.97
Molecular biology of breast cancer stem cells: potential clinical applications. Cancer Treat Rev (2010) 0.97
Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries. BMC Cancer (2004) 0.96
Survival benefit with radiation therapy in node-positive breast carcinoma patients. Strahlenther Onkol (2009) 0.95
Modeling the effect of age in T1-2 breast cancer using the SEER database. BMC Cancer (2005) 0.95
Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience. Int J Radiat Oncol Biol Phys (2011) 0.94
Can 18-FDG-PET during radiotherapy replace post-therapy scanning for detection/demonstration of tumor response in head-and-neck cancer? Int J Radiat Oncol Biol Phys (2010) 0.94
Feasibility of Tomotherapy to spare the cochlea from excessive radiation in head and neck cancer. Oral Oncol (2011) 0.94
Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial. Int J Radiat Oncol Biol Phys (2012) 0.94
Post-surgery radiation in early breast cancer: survival analysis of registry data. Radiother Oncol (2002) 0.94
Phase II study of preoperative helical tomotherapy for rectal cancer. Int J Radiat Oncol Biol Phys (2007) 0.92
Assessment of rectal distention in radiotherapy of prostate cancer using daily megavoltage CT image guidance. Radiother Oncol (2009) 0.92
Effect of the number of uninvolved nodes on survival in early breast cancer. Oncol Rep (2003) 0.92
Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography. Int J Radiat Oncol Biol Phys (2008) 0.91
Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy. Int J Radiat Oncol Biol Phys (2010) 0.91
The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence. Maturitas (2009) 0.91
Prognostic value of nodal ratios in node-positive breast cancer: a compiled update. Future Oncol (2009) 0.91
Dosimetric comparison of different treatment modalities for stereotactic radiosurgery of arteriovenous malformations and acoustic neuromas. Radiother Oncol (2012) 0.90
Evaluation of dose calculation algorithms for dynamic arc treatments of head and neck tumors. Radiother Oncol (2002) 0.90
Considerations on treatment efficiency of different conformal radiation therapy techniques for prostate cancer. Radiother Oncol (2002) 0.89
Omission of radiotherapy after breast-conserving surgery: survival impact and time trends. Radiother Oncol (2003) 0.89
Hypoxic tumor cell radiosensitization through nitric oxide. Nitric Oxide (2008) 0.89
Effectiveness of intensity-modulated and image-guided radiotherapy to spare the mandible from excessive radiation. Oral Oncol (2012) 0.89
Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients? Nucl Med Commun (2010) 0.89
TomoTherapy: implications on daily workload and scheduling patients. Radiother Oncol (2007) 0.89
Effectiveness of image-guided radiotherapy for laryngeal sparing in head and neck cancer. Oral Oncol (2010) 0.88
Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer. Jpn J Clin Oncol (2004) 0.88
Breast conserving treatment for breast cancer: dosimetric comparison of different non-invasive techniques for additional boost delivery. Radiat Oncol (2014) 0.88
Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer. Strahlenther Onkol (2008) 0.87
Loco-regional treatment in metastatic breast cancer patients: is there a survival benefit? Breast Cancer Res Treat (2010) 0.87
Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer. Int J Radiat Oncol Biol Phys (2011) 0.87